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Background: The so-called canine vector-borne diseases (CVBD) are caused by a wide range of pathogens transmitted by
arthropods. In addition to their veterinary importance, many of these canine vector-borne pathogens can also affect the
human population due to their zoonotic potential, a situation that requires a One Health approach. As the prevalence of
vector-borne pathogens in cats from southern Portugal has been recently evaluated, the aim of the present study was to
assess if the same agents were present in dogs living in the same area, and to assess positivity-associated risk factors.
Methods: One thousand and ten dogs (521 domestic and 489 stray) from veterinary medical centres and animal shelters
in southern Portugal were enrolled. Anaplasma spp./Ehrlichia spp., Bartonella spp., Borrelia burgdorferi sensu lato, Babesia
spp., Hepatozoon spp. and Leishmania infantum infections were evaluated by polymerase chain reaction (PCR) assays in
blood samples.
Results: Sixty-eight (6.7%) dogs were PCR-positive to at least one of the tested CVBD agent species, genera or complex,
including one dog found positive to two different genera. Nineteen (1.9%) dogs were positive to Anaplasma spp./Ehrlichia
spp., eight (0.8%) to B. burgdorferi s.l., 31 (3.1%) to Hepatozoon spp. and 11 (1.1%) to L. infantum. Anaplasma platys, Ehrlichia
canis, B. burgdorferis.l. and Hepatozoon canis were identified by DNA sequencing, including one animal confirmed with both
A. platys and H. canis. Furthermore, Wolbachia spp. was amplified in blood from four dogs. None of the tested dogs was
positive by PCR for Bartonella spp. or Babesia spp.
Conclusions: The molecular identification of CVBD agents in southern Portugal, some of them with zoonotic concern,
reinforces the importance to alert the veterinary community, owners and public health authorities to prevent the risk of
transmission of vector-borne pathogens among dogs and to other vertebrate hosts including humans. The prevalence of
the selected pathogens was lower than that previously found in cats from the same region, probably because veterinarians
and owners are more aware of them in the canine population and control measures are used more often.
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Canine vector-borne diseases (CVBD) comprise a group
of globally distributed and spreading illnesses that are
caused by a wide range of pathogens transmitted by ar-
thropods [1-4]. In addition to their veterinary importance,
many of these canine vector-borne pathogens can also
affect the human population due to their zoonotic poten-
tial, a situation that requires a One Health approach [5,6].
Anaplasma phagocytophilum and Anaplasma platys
cause canine granulocytic anaplasmosis and infectious
canine cyclic thrombocytopenia, respectively. Both
agents can infect a range of domestic and wild vertebrate
hosts, including dogs and humans [7-10]. A. phagocyto-
philum is transmitted by ticks of the genus Ixodes and
A. platys presumably by the Rhipicephalus sanguineus
ticks. In Portugal A. platys DNA has been detected in
clinically suspect dogs living in the north and south of
Portugal [11,12], while the overall national seropreva-
lence of Anaplasma spp. has ranged from 4.5% in appar-
ently healthy to 9.2% in clinically suspect dogs [3].
Ehrlichia canis (transmitted by R. sanguineus) is a causa-
tive agent of acute or chronic canine monocytic ehrlichi-
osis. E. canis has been molecularly detected in dogs
from the north [12,13] and from the south of Portugal
[14]. Seroprevalence at the national level ranged from
4.1% in apparently healthy dogs to 16.4% in animals clin-
ically suspected of a CVBD [3].
Seven Bartonella species transmitted by several arthro-
pod vectors, including fleas and Ixodes spp. ticks, have
been implicated as canine pathogens [15]. To date, no dog
with Bartonella spp. infection has been reported in
Portugal. Spirochetes belonging to the Borrelia burgdorferi
sensu lato complex are the agents of Lyme borreliosis. In
Europe, B. burgdorferi s.l. is mainly transmitted by I. rici-
nus [16]. Though few infected dogs show similar clinical
signs, most of them are subclinical hosts [17] and can be
sentinels for this infection. In Portugal, seropositivity to B.
burgdorferi s.l. has ranged from 0.2% in apparently healthy
dogs to 0.5% in clinical suspected animals in a country-
wide investigation [3].
Canine piroplasmosis or babesiosis, mainly caused by sev-
eral Babesia spp. haemoparasites, is a protozoal tick-borne
disease with worldwide distribution [18]. Babesia canis
(transmitted by Dermacentor reticulatus), Babesia vogeli
(transmitted by R. sanguineus) and the Babesia microti-like
piroplasm (syn. Theileria annae) were molecularly con-
firmed for the first time in Portugal in dogs from the north
of the country [19,20]. Canine hepatozoonosis caused by the
protozoan Hepatozoon canis transmitted by the ingestion of
R. sanguineus is a common infection of dogs from the Old
World [21]. H. canis has already been molecularly detected
in dogs from the north [13,22] and from the south of
Portugal [23]. Canine leishmaniosis (CanL), a zoonotic dis-
ease endemic in southern Europe is caused by the protozoanL. infantum transmitted by Phlebotomus spp. sand flies [24].
CanL is endemic in Portugal, with an overall national sero-
prevalence of 6.3% [25].
As the prevalence of vector-borne pathogens in cats
from southern Portugal was recently evaluated [26], the
aim of the present study was to assess if the same agents
with veterinary and zoonotic importance were present in




From December 2011 to April 2014, a total of 1,010
dogs (521 domestic and 489 stray), from veterinary med-
ical centres and animal shelters in southern Portugal,
were studied (Table 1). Animals were from the districts
of Lisbon (n = 305), Setúbal (n = 453, which include 24
dogs from the contiguous districts of Évora and Beja)
and Faro (n = 252).
Domestic dogs were randomly included after owners’
informed consent. Consent for enrolment of stray dogs
was obtained from the person in charge of each shelter.
Out of the 489 stray animals, 457 were sheltered for
adoption, and 32 others were captured and euthanized
in the scope of official animal control programs.
Whole blood samples (1–2 ml) were collected by cephalic
or jugular venipuncture and spotted onto filter paper for
DNA extraction. Samples were dried at room temperature
and kept at 4°C until tested. Whenever available, data on the
region, breed, gender, age, living conditions, use of acari-
cides/insecticides and clinical status (presence or absence of
signs compatible with a CVBD) were registered for each dog
(Table 1). Clinical signs comprised anorexia, muscular
atrophy, dermatological manifestations, epistaxis, exercise
intolerance, fever, gastrointestinal alterations, lameness, leth-
argy, lymphadenopathy, onychogryphosis, ocular manifesta-
tions, pale mucous or weight loss.
This study was ethically approved by the boards of the
IHMT-UNL and of the Faculty of Veterinary Medicine
(ULHT) as complying with the Portuguese legislation for
the protection of animals (Law no. 92/1995).
PCR amplification and DNA sequencing
A commercial kit (Kit Citogene®, Citomed, Portugal) was
used to extract DNA from blood on filter paper. Four discs
of filter paper (4 mm in diameter each) were incubated with
lysis buffer (150 μl) and 1.5 μl of proteinase K (20 mg/ml).
Further DNA extraction followed the kit manufacturer’s
instructions.
Positivity to Anaplasma spp./Ehrlichia spp., Bartonella
spp., B. burgdorferi s.l., Babesia spp., Hepatozoon spp. and
L. infantum DNA in blood samples was tested by PCR ac-
cording to previously described protocols (Table 2). PCR
amplifications were performed in a 25 μl final volume
Table 1 Prevalence of vector-borne pathogen species, gender or complex as detected by PCR in 1,010 dogsfrom
southern Portugal
Variable//category N° of characterized
dogs (%)
N° of positive dogs (%)
Anaplasma/Ehrlichia B. burgdorferi s.l. Hepatozoon L. infantum ≥1 pathogen
Region 1,010
Lisboa 305 (30.2) 1 (0.3)a 1 (0.3) 2 (0.7)a 7 (2.3) 11 (3.6)a
Setúbal 453 (44.9) 2 (0.4)b 3 (0.7) 10 (2.2)b 3 (0.7) 17 (3.8)b
Algarve 252 (25.0) 16 (6.3)a,b 4 (1.6) 19 (7.5)a,b 1 (0.4) 40 (15.9)a,b
Breed 793
Defined 344 (43.4) 4 (1.2) 3 (0.9) 8 (2.3) 6 (1.7) 21 (6.1)
Mongrel 449 (56.6) 12 (2.7) 5 (1.1) 18 (4.0) 4 (0.9) 39 (8.7)
Gender 1,004
Female 504 (50.2) 9 (1.8) 5 (1.0) 15 (3.0) 4 (0.8) 33 (6.5)
Male 500 (49.8) 9 (1.8) 3 (0.6) 14 (2.8) 7 (1.4) 33 (6.6)
Age (months) 938
[1-11] 73 (7.8) 3 (4.1) 2 (2.7) 0 (0.0) 0 (0.0) 5 (6.8)
[12–83] 576 (61.4) 10 (1.7) 4 (0.7) 15 (2.6) 7 (1.2) 36 (6.3)
[84–228] 289 (30.8) 3 (1.0) 1 (0.3) 7 (2.4) 3 (1.0) 14 (4.8)
Lifestyle 1,010
Domestic 521 (51.6) 15 (2.9)a 6 (1.2) 19 (3.6) 6 (1.2) 45 (8.6)a
Stray 489 (48.4) 4 (0.8)a 2 (0.4) 12 (2.5) 5 (1.0) 23 (4.7)a
Housing 852
Indoors 63 (7.4) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)a,b
Mixed 182 (21.4) 5 (2.7) 3 (1.6) 11 (6.0) 0 (0.0) 19 (10.4)a
Outdoors 607 (71.2) 11 (1.8) 4 (0.7) 18 (3.0) 5 (0.8) 38 (6.3)b
Acaricides-insecticides 963
Yes 448 (46.5) 5 (1.5) 4 (0.8) 10 (2.2) 6 (1.3) 25 (5.6)
No 515 (53.5) 12 (2.3) 4 (0.8) 19 (3.7) 4 (0.8) 38 (7.4)
Clinical status 906
Non-suspect 700 (77.3) 12 (1.7) 5 (0.7) 26 (3.7) 7 (1.0) 49 (7.0)
Suspect 206 (22.7) 6 (2.9) 2 (1.0) 3 (1.5) 3 (1.5) 14 (6.8)
Total 1,010 19 (1.9) 8 (0.8) 31 (3.1) 11 (1.1) 68 (6.7)
a,bStatistically significant difference for the same agent between categories of the same variable (p < 0.05).
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(Nyztech, Portugal), 1 μl of each primer (10 pmol) and 3 μl
of DNA template. In all amplifications a positive control
containing genomic target DNA and a negative control
without DNA were included. The reaction mixtures were
cycled in a Thermo Electron Corporation® Px2 Termal Cy-
cler (VWR, USA). PCR products were visualized under UV
illumination after electrophoresis migration on a 1.5% gel
agarose stained with GreenSafe Premium® (Nzytech), using
a 100 bp DNA ladder as a marker.
PCR products were purified with a High Pure PCR
Product Purification Kit (Roche®, Germany) according to
the manufacturer’s instructions and directly sequenced
(one direction) (Stabvida®, Portugal), using the same
primers as those used for the DNA amplification.Species identity of the obtained sequences was deter-
mined according to the closest BLAST match (identity ≥
99% for the first 30 matches) to a GenBank® accession
and deposited in DNA Data Bank of Japan (DDBJ)
(http://www.DDBJ.nig.ac.jp).Statistical analysis
Percentages of positivity to CVBD agents were compared
by the Chi-square or Fisher’s exact tests. A p value < 0.05
was considered as statistically significant. The exact bino-
mial test was used to calculate confidence intervals for the
proportions, with a 95% confidence level (CI). Analyses
were performed with SPSS® 21 software for Windows and
with StatLib.
Table 2 Primers sets for PCR amplification of CVBD agents
Pathogen Primers Product size (bp) Reference
Anaplasma spp./Ehrlichia spp. EHR16SD: 5'-GGT ACC YAC AGA AGA AGTCC-3' 345 [27]
EHR16SR: 5'-TAG CAC TCA TCG TTT ACAGC-3'
Bartonella spp. 325 s: 5'-CTTCAGATGATGATCCCAAGCCTTCTGGCG-3' 500-800 [28]
1100as: 5'-GAACCGACGACCCCCTGCTTGCAAAGCA-3'
Borrelia burgdorferi s.l. Outer primers: 774 [29]
132f: 5'-TGGTATGGGAGTTTCTGG-3'
905r: 5'-TCTGTCATTGTAGCATCTTT-3'
Inner primers: 604 [29]
220f: 5'-CAGACAACAGAGGGAAAT-3'
823r: 5'-TCAAGTCTATTTTGGAAAGCACC-3'
Babesia spp. PIRO-A: 5'-AAT ACC CAA TCC TGA CACAGG G-3' 400 [27]
PIRO-B: 5'-TTA AAT ACG AAT GCC CCCAAC-3'
Hepatozoon spp. HEP-F: 5'-ATA CAT GAG CAA AAT CTC AAC-3' 626-666 [30]
HEP-R: 5'-CTT ATT ATT CCA TGC TGC AG-3'
Leishmania infantum MC1: 5’-GTTAGCCGATGGTGGTCTTG-3’ 447 [31]
MC2: 5’-CACCCATTTTTCCGATTTTG-3’
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Sixty-eight (6.7%; CI: 5.3-8.5%) dogs were PCR-positive to at
least one of the tested species, genera or complex of CVBD
agents (Table 1). Nineteen (1.9%; CI: 1.1-2.9%) dogs were
positive to Anaplasma spp./Ehrlichia spp., eight (0.8%; CI:
0.3-1.5%) to B. burgdorferi s.l., 31 (3.1%; CI: 2.1-4.3) to Hepa-
tozoon spp. and 11(1.1%; CI: 0.5-1.9) to L. infantum (Table 3).
Wolbachia spp. DNA (amplified with the same primers used
to detect Anaplasma spp./Ehrlichia spp.) was detected in
four dogs, while DNA of Bartonella spp. or Babesia spp.
was not amplified from any dog in the study.
As shown in Table 1, the prevalence of Anaplasma spp/
Ehrlichia spp. was statistically higher in domestic dogs.




Anaplasma spp./Ehrlichia spp. 1
[Anaplasma platys] [
[Ehrlichia canis] [





Anaplasma spp./Ehrlichia spp. and Hepatozoon spp. 1
[A. platys and H. canis] [
Total 6higher in dogs living in the Algarve region. Statistically sig-
nificant differences were also found for PCR positivity to
at least one of the studied agents in domestic dogs, in dogs
with access to outdoors and in dogs living in the Algarve
region.
Sequencing confirmed A. platys in five, E. canis in five,
B. burgdorferis.l. in six and H. canis in 18 dogs, including
one animal with both A. platys and H. canis (Table 3); and
revealed Wolbachia spp. (DDBJ accessions: LC018189 to
LC018192) in four dogs.
Discussion
This is the most comprehensive study carried out in dogs
from southern Portugal on the prevalence of infectiond/or complex of CVBD agents in 1,010 dogs from
o. positive dogs (%) DDBJ accessions
7 (6.6)
8 (1.8)
4 (0.4)] [LC018179 to LC018182]
5 (0.5)] [LC018184 to LC018188]
(0.8) [LC018211 to LC018216]
0 (3.0)




1 (0.1)] [LC018183 and LC018210]
8 (6.7)
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with and without clinical signs compatible with a vector-
borne disease. DNA from these pathogens taken all together
was less frequently detected in dogs (6.7%; p < 0.001) than in
cats (29.9%; 194/649) from the same region [26]. Further-
more, only one (0.1%) dog was found co-infected (with two
pathogens), whereas 29 (4.5%) cats were positive to two
agents and four (0.6%) cats to three agents [26].
In this study A. platys has been molecularly confirmed to
infect dogs from the south of the country, corroborating
previous detection of this bacterium in dogs [11,23] and in
R. sanguineus [32] from the same region. The prevalence of
positivity to Anaplasma/Ehrlichia in this work (1.9%) was
lower than the 4.0% obtained in Spain [33] and the 3.7-6.0%
in Italy [34], which might be related with the targeted popu-
lation. In fact, in the works of Tabar et al. [33] and Trotta
et al. [34], all the positive dogs were sick animals with
clinical signs compatible with vector-borne diseases and
admitted for medical treatment, while in the present work
most of the enrolled animals were apparently healthy. Inter-
estingly, in our study most of the animals harbouring
Anaplasma/Ehrlichia DNA were from Faro, overlapping
the Algarve region, the southern most district of continen-
tal Portugal, which seem to follow the trend revealed by
Cardoso et al. [3] that the prevalence of antibodies against
Anaplasma spp. and E. canis in dogs from southern
Portugal was significantly higher than in dogs from the
northern and central regions of the country.
In the present work, B. burgdorferi s.l. DNA was ampli-
fied from 0.8% of the screened animals, providing the first
molecular evidence of naturally occurring B. burgdorferi s.
l. infection in dogs from Portugal. The exposure of dogs to
these spirochetes was previously demonstrated by specific
serology in the Algarve [35] and in the Alentejo and
Lisbon regions [3]. Furthermore, B. burgdorferi s.l. genos-
pecies, Borrelia lusitaniae was isolated from humans
[36-38] and DNA of B. burgdorferi s.l. was detected in
ticks [32,39] and cats from the south of the country [26].
Nevertheless, information on the clinical signs associated
with Borrelia infections in dogs and their role as sentinels
is still limited [6].
H. canis was the most prevalent pathogen detected in all
the assessed dogs, with a significantly higher prevalence in
animals living in the Algarve. In fact, H. canis has recently
been identified in dogs [23], in R. sanguineus collected
from dogs living in this region [32], and also in foxes from
the south [40], showing that the protozoan is widespread
in this area of the country. Although in this study only
three out of the 31 infected dogs presented clinical signs,
subclinical infections should not be neglected as they may
progress to a severe disease and warrant treatment [41].
Concurrent infections of H. canis with other canine patho-
gens are common [21]; however, in the present work only
one animal apparently healthy was co-infected with A.platys and the protozoan. Although this individual dog
had no clinical signs of a CVBD, co-infections may po-
tentiate disease pathogenesis, altering clinical manifesta-
tions associated with single infections [42].
The overall prevalence of L. infantum infection in the
present study (1.1%) was much lower (p < 0.001) than
the 34.9% obtained in 152 dogs from Lisbon [43]. The
lower detection of Leishmania DNA might be due to
the: (i) dynamics of infection over time, which may de-
pend on the abundance and distribution of the proven
vector species in conjunction with the number of in-
fected vertebrate hosts [44], and (ii) insufficient data re-
garding the duration of parasitaemia in infected dogs. In
fact, and taking into account a seroprevalence of 18.2%
recently obtained in 170 dogs from the Algarve region
[45], PCR with blood should be used to complement
serological results and not only by itself to detect Leish-
mania infection, as it can lead to false negative results,
especially in subclinically infected dogs [46].
PCR-positivity to one or more genera/complex of
CVBD agents was found to be associated with domestic
dogs, with animals living in the Algarve and with an out-
door or mixed (i.e. with outdoor access) housing. In fact,
most of the domestic dogs harbouring DNA of the stud-
ied pathogens lived in rural areas from the Algarve re-
gion and used to spend most of their time exclusively
outdoors, thus increasing their exposure to arthropod
vectors and the agents they might transmit.
The role of domestic dogs as reservoirs of Bartonella
spp. is less clear than for cats, and the former are probably
accidental hosts. Nevertheless, they are excellent sentinels
for human infections because a similar disease spectrum
develops in dogs [47]. Serologic and molecular evidence of
Bartonella henselae and Bartonella clarridgeiae exist for
cats from the south of Portugal [26,48]. Thus, the non-
detection of Bartonella DNA in the present study might
be related with differences in immune responses, host
preference of particular vectors or innate resistance in
dogs to these bacteria. On the other hand, the definitive
diagnosis of Bartonella infection is challenging due to the
fastidious nature and intracellular tropism of these bac-
teria for erythrocytes and endothelial cells [49]. According
to Perez et al. [50], enrichment culture and subculture,
followed by PCR amplification, enhances molecular diag-
nostic sensitivity in dogs. Thus, it is possible that the PCR
done directly from blood samples might have missed some
positive cases; nevertheless, the prevalence of infection at
the population level, if any, must be very low.
Albeit the detection of B. canis, B. vogeli and the B.
microti-like piroplasm has already been reported in dogs
from the north of Portugal [13,19,20,22] and B. vogeli in
dogs from the south of the country [23], in the present
study none of the screened animals harboured piroplasmid
DNA. The non-detection of B. canis could somehow be
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the north of the country. However, the absence of B. vogeli
and B. microti-like DNA is more difficult to explain, since
both have already been detected in southern Portugal, the
former in cats [26], dogs [23] and ticks [32], and the latter
in foxes [51]. According to a recent questionnaire-based
survey on the distribution of canine babesiosis in western
Europe, the annual incidence of this parasitosis in southern
Spain, which is geographically close to the area surveyed in
this study, was estimated to be 0.0-0.7% [52]. Furthermore,
a 58% prevalence of antibodies anti-Babesia spp. was re-
ported among 331 dogs from kennels/shelters in southern
Portugal [53]. The absence of Babesia spp. infection in the
present study might be related with differences in the gen-
etic background/immune system or between vector-dog in-
teractions. Further studies are needed to better understand
the epidemiological importance of these findings.
Conclusion
The identification of CVBD agents in southern Portugal,
some of them with zoonotic concern, reinforces the im-
portance to alert the veterinary community, owners and
public health authorities to prevent the risk of transmission
of vector-borne pathogens among dogs and to other verte-
brate hosts including humans. Interestingly, the prevalence
of the selected pathogens was much lower than that previ-
ously found in cats from the same region [26], probably be-
cause veterinarians and owners are much aware of them in
the canine population and prophylatic measures such as in-
secticides and acaricides are used.
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